MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specialising in the development of novel ...

* PATIENT RECRUITMENT RATES FROM THIS TRIAL NOW INDICATE DATA WILL BE AVAILABLE BY MID-YEAR 2021, WHICH IS LATER THAN PREVIOUSLY ANNOUNCED * "AUDIBLE-S TRIAL IS PROGRESSING BUT WE ARE OBVIOUSLY ...